Düsseldorf The first fiscal year of the new Bayer boss Bill Anderson will be an unusually bad one for the pharmaceutical company: the net debt will rise again significantly to 36 billion euros by the end of 2023. The last time the debt mountain was so high at the end of a financial year was directly after the takeover of Monsanto in 2018. But at the same time the group cannot generate any free funds (free cash flow) this time with which it could noticeably reduce the oppressive debt burden.
Read on now
Get access to this and every other article in the
Web and in our app free of charge for 4 weeks.
Read on now
Get access to this and every other article in the
web and in our app.
Further
2023-08-20 23:52:25
#Pharmaceutical #chemical #group #Bayer #groaning #high #debts #CEO #deliver
